The natural plant product sophocarpine ameliorates dextran sodium sulfate-induced colitis in mice by regulating cytokine balance

International Journal of Colorectal Disease

Volumn 27, Issue 5, 2012, Pages 575-581

  Wang, Xiao Juan ^a   Deng, Hong Zhu ^a   Jiang, Bin ^a   Yao, Hui ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

C57BL 6 mice; Dextran sulfate sodium; Sophocarpine; Ulcerative colitis

Indexed keywords

CYTOKINE; HERBACEOUS AGENT; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 6; MYELOPEROXIDASE; SALAZOSULFAPYRIDINE; SOPHOCARPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLON WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DRUG RESPONSE; ENZYME ACTIVITY; FEMALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ULCERATIVE COLITIS;

ALKALOIDS; ANIMALS; COLITIS, ULCERATIVE; COLON; CYTOKINES; DEXTRAN SULFATE; DRUGS, CHINESE HERBAL; FEMALE; INTERLEUKIN-1; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKINS; MICE; MICE, INBRED C57BL; PEROXIDASE;

EID: 84863003945     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-011-1352-z     Document Type: Article

References (20)

1. Eaden JA, Mayberry JF (2002) Guidelines for screening surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 51(Supp l 5):v10-v12
2. Boyer DL, Li BU, Fyda JN, Friedman RA (1989) Sulfasalazine-induced hepatotoxicity in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 8:528-532
3. Vihinen MK, Kolho KL, Janne OA, Andersson S, Raivio T (2009) Circulating adiponectin as a marker for glucocorticoid-related side effects in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 48:504-506
4. Chen JG, Deng HZ (2006) Effects of total base of Sophora alopecuroides on expression of SOD, MDA, NO, MPO in rats with experimental colitis. Zhongguo Zhong Yao Za Zhi 31:323-325
5. Yi Z, Hong-zhu D, Zi-hua D, Jian-guo C, Yan C (2006) Effects of the total base of Sophora alopecuroides on the expressions of CD4 +CD25+ and CD8+CD28-Tregs in rats with experimental colitis. Chin J Clin Rehabil 47:89
6. Liu M, Liu XY, Cheng JF (2003) Advance in the pharmacological research on matrine. Zhongguo Zhong Yao Za Zhi 28:801-804
7. Jiang H, Hou C, Zhang S, Xie H, Zhou W, Jin Q, Cheng X, Qian R, Zhang X (2007) Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells. Eur J Pharmacol 559:98-108
8. Azzam HS, Goertz C, Fritts M, Jonas WB (2007) Natural products and chronic hepatitis. C virus Liver Int 27:17-25
9. Zhang MJ, Huang J (2004) Recent research progress of anti-tumor mechanism matrine. Zhongguo Zhong Yao Za Zhi 29:115-118
10. Ma L, Wen S, Zhan Y, He Y, Liu X, Jiang J (2008) Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med 74:245-251
11. Gao Y, Li G, Li C, Zhu X, Li M, Fu C, Li B (2009) Anti-nociceptive and anti-inflammatory activity of sophocarpine 125:324-329
12. Zhang Y, Wang S, Li Y, Xiao Z, Hu Z, Zhang J (2008) Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice. Int J Pharmacol 8(13-14):1772-1776
13. Chen SX, Chen MF, Qian FR, Xie LS (2005) A clinical research of sophocarpine in treatment of viral myocarditis. J Clin Cardiol 21:608-611
14. Wang Y (2004) Studies on anti-inflammatory and anti-parasitic effects of Sophocarpine. Inner Mongolia Agricultural University 19-20
15. Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12:S3-S9
16. Shanahan F (2001) IBD: immunodiagnostics immunotherapy eutics and ectotherapeutics. Gastroenterology 120:622-635
17. Rogler G, Andus T (1998) Cytokines in inflammatory bowel diseases. World J Surg 22:382-389
18. Nielsen OH, Køppen T, Rüdiger N, Horn T, Eriksen J, Kirman I (1996) Involvement of interleukin-4 and-10 in inflammatory bowel disease. Dig Dis Sci 41:1786-1793
19. Cooper HS, Murthy SNS, Shah RS, Sedergran DJ (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69:238-249
20. Kitajima S, Takuma S, Morimoto M (1999) Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim 48:137-143